BIOTICA TECHNOLOGY LIMITED

Patent Owner

Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 980
 
 
 
C07D HETEROCYCLIC COMPOUNDS 6138
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 498
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3147
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2245
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 180
 
 
 
C07K PEPTIDES 1113

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,008,318 39-desmethoxy derivatives of rapamycinDec 03, 09Aug 30, 11[A61P]
7,897,608 39-desmethoxy-39-methyl derivatives of rapamycinNov 19, 08Mar 01, 11[C07D, A61K]
7,807,418 Method for producing hybrid polyketide synthasesJul 12, 04Oct 05, 10[C07H, C12P]
7,807,800 Erythromycins and process for their preparationNov 29, 04Oct 05, 10[C07H]
7,803,808 Production of polyketides and other natural productsAug 11, 05Sep 28, 10[C07D, A61K]
7,655,673 39-desmethoxyrapamycin, compositions and methods of use thereofJan 10, 07Feb 02, 10[A61K]
7,648,996 39-desmethoxy derivatives of rapamycinMar 10, 06Jan 19, 10[C07D, A61K]
7,595,175 Polyketides and their synthesisAug 14, 01Sep 29, 09[C12N, C12P, C07K]
7,482,137 Hybrid glycosylated products and their production and useOct 12, 06Jan 27, 09[C12N, C07H, C12P]
7,390,895 Production of polyketides and other natural productsJul 16, 07Jun 24, 08[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2011/0091,452 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell MalignanciesMar 30, 07Apr 21, 11[C12N, C07D, C12P, A61K]
2011/0027,185 Methods of Screening for Anti-Angiogenic CompoundsJul 14, 08Feb 03, 11[C07D, A61P, G01N, A61K, C07K]
2010/0068,203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell MalignanciesMay 09, 07Mar 18, 10[C12N, C07D, A61P, C12P, A61K]
2010/0061,994 MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOFMar 10, 06Mar 11, 10[A61P, A61K]
2009/0312,316 NOVEL COMPOUNDSMay 17, 07Dec 17, 09[C07D, A61P, A61K]
2009/0298,804 Novel Compounds and Methods for Their ProductionMar 30, 07Dec 03, 09[C12N, C07D, C12P, A61K]
2009/0253,667 18 ,21-Didesoxymacbecin Derivatives for the Treatment of CancerMay 09, 07Oct 08, 09[C12N, C07D, C12P, A61K]
2009/0209,507 15-O-Desmethylmacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell MalignanciesMar 30, 07Aug 20, 09[C12N, C07D, C12P, A61P, A61K]
2009/0209,572 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other DisordersNov 19, 08Aug 20, 09[C07D, A61K]
7,560,252 Borrelidin-producing polyketide synthase and its useDec 24, 03Jul 14, 09[C07H, C12P]
2009/0117,127 Novel Compounds and Methods for Their ProductionMar 30, 07May 07, 09[C12N, C07D, A61P, C12P, A61K]
7,381,546 Polyketides and their synthesis and useJan 10, 06Jun 03, 08[C12P]
2008/0044,860 Polyketides and Their SynthesisNov 29, 04Feb 21, 08[C12N, C07H, C07G]
2007/0059,689 Hybrid glycosylated products and their production and useNov 29, 02Mar 15, 07[C07H, C12P, C12Q, C07K]
7,018,808 Polyketides and their synthesis and useDec 02, 02Mar 28, 06[C12P]
6,271,255 Erythromycins and process for their preparationSep 16, 99Aug 07, 01[C07D, A61K]

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.